Effect of leukotriene receptor antagonist on cough variant asthma / 南方医科大学学报
Journal of Southern Medical University
;
(12): 694-696, 2009.
Article
in Chinese
| WPRIM
| ID: wpr-233708
ABSTRACT
<p><b>OBJECTIVE</b>To study the curative effect of leukotriene receptor antagonist on cough variant asthma (CVA).</p><p><b>METHODS</b>Sixty-four CVA patients received treatment with bricany and montelukas and 68 control patients had bricany treatment for 4 weeks. The recurrence rate was observed in the two groups during the follow-up for 6 months.</p><p><b>RESULTS</b>The remission time of two groups were 2.5-/+3.6 and 5.3-/+3.8 days in acute phase, respectively, showing a significant difference between them (P<0.05). The recurrence rate of the two groups within 6 months were 20.09% and 40.87%, respectively, showing also significantly differences (P<0.05).</p><p><b>CONCLUSION</b>Leukotriene receptor antagonist and bricany can effectively control CVA and significantly lower the short-term recurrence rate of CVA.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pharmacology
/
Recurrence
/
Asthma
/
Case-Control Studies
/
Follow-Up Studies
/
Receptors, Leukotriene
/
Leukotriene Antagonists
/
Cough
/
Therapeutic Uses
/
Drug Therapy
Type of study:
Observational study
/
Prognostic study
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
Chinese
Journal:
Journal of Southern Medical University
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS